E71.540 Rhizomelic chondrodysplasia punctata

Name of the Condition

• Rhizomelic chondrodysplasia punctata

Summary

Rhizomelic chondrodysplasia punctata is a rare genetic disorder affecting bone development, growth, and metabolic processes. It is characterized by shortening of the proximal limbs (rhizomelia), distinctive facial features, and abnormalities in the nervous system. The condition results from impaired peroxisome function, leading to the accumulation of toxic substances and deficiency of essential metabolites.

Causes

Rhizomelic chondrodysplasia punctata is caused by mutations in genes involved in peroxisome biogenesis or function, such as PEX7 or GNPAT. These mutations disrupt the organelle's ability to break down fatty acids, produce bile acids, and detoxify harmful compounds, resulting in metabolic imbalances and developmental abnormalities.

Risk Factors

• Autosomal recessive inheritance pattern.
• Family history of the disorder.
• Consanguineous relationships (parents who are closely related).

Symptoms

• Shortening of the upper limbs (rhizomelia).
• Distinctive facial features (e.g., flattened nasal bridge, cataracts).
• Developmental delays or intellectual disability.
• Seizures or abnormal muscle tone.
• Respiratory or feeding difficulties in infancy.

Diagnosis

Diagnosis involves clinical evaluation of physical features, radiographic imaging to detect bone abnormalities (e.g., punctate calcifications), and biochemical testing to measure peroxisomal metabolites (e.g., plasmalogens) in blood or urine. Genetic testing confirms mutations in associated genes.

Treatment Options

Treatment is supportive and focuses on managing symptoms. Interventions may include physical therapy for mobility, seizure management, nutritional support, and monitoring for respiratory or vision complications. No cure exists for the underlying genetic defect.

Prognosis and Follow-Up

Prognosis is poor, with most affected individuals experiencing severe developmental delays and reduced life expectancy. Regular follow-up with a multidisciplinary team (e.g., neurologists, orthopedists, geneticists) is essential to address complications and provide supportive care.

Complications

• Severe intellectual disability.
• Respiratory infections or failure.
• Vision or hearing loss.
• Skeletal deformities requiring orthopedic intervention.

Lifestyle & Prevention

• Genetic counseling for families to understand recurrence risks.
• Prenatal testing (e.g., chorionic villus sampling) may be considered for at-risk pregnancies.
• Supportive care to optimize quality of life and manage symptoms.

When to Seek Professional Help

Seek immediate medical attention for:

• New or worsening seizures.
• Difficulty breathing or feeding.
• Sudden changes in behavior or mobility.
• Signs of infection (e.g., fever, respiratory distress).

Tips for Medical Coders

Document the presence of characteristic features (e.g., rhizomelia, cataracts) and confirmatory diagnostic tests (e.g., biochemical or genetic testing) to support code assignment. Ensure documentation aligns with the clinical criteria for rhizomelic chondrodysplasia punctata to justify the use of E71.540.